Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03581773
What this trial is testing

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

Who this might be right for
MucositisStomatitis
Niels Fristrup 84
Testing effectiveness (Phase 2)Study completedNCT00512681
What this trial is testing

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 44
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Early research (Phase 1)Study completedNCT00960557
What this trial is testing

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

Who this might be right for
Neoplasm Metastasis
Mateon Therapeutics 16
Early research (Phase 1)Study completedNCT03993327
What this trial is testing

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal Carcinoma Metastatic in the LiverMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+3 more
City of Hope Medical Center 4
Not applicableStudy completedNCT02722395
What this trial is testing

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer From Any Cancer Site
Duke University 5
Early research (Phase 1)Study completedNCT01548482
What this trial is testing

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00056446
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis Pharmaceuticals 855
Not applicableLooking for participantsNCT07139418
What this trial is testing

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy

Who this might be right for
Gastric Carcinoma
Jichao Qin 400
Testing effectiveness (Phase 2)Ended earlyNCT03251417
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 11
Early research (Phase 1)Study completedNCT02048384
What this trial is testing

Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Large-scale testing (Phase 3)Active Not RecruitingNCT05506943
What this trial is testing

CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
Compass Therapeutics 168
Not applicableWithdrawnNCT06929338
What this trial is testing

XDRIVE in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colon CancerMetastatic Rectal Adenocarcinoma+2 more
First Ascent Biomedical Inc.
Large-scale testing (Phase 3)Study completedNCT00012389
What this trial is testing

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi
Next Page